July 26, 2007 - St. Jude Medical Inc. announced that the FDA has granted clearance for the 7F Proxis Embolic Protection System, a system designed to extract debris that may become dislodged when an intervention, such as delivering a stent, is performed on patients who have previously undergone a heart bypass procedure using a saphenous vein graft (SVG).

July 26, 2007 - St. Jude Medical Inc. announced that the U.S. FDA cleared the ACross Transseptal Access System, a device designed to improve control and simplify the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation, in addition to receiving a Health Canada License.

July 26, 2007 - CardiacAssist Inc., a Pittsburgh-based medical device company, announced it has completed the 1000th worldwide procedure utilizing the TandemHeart System, which is used in 20 ranked heart and heart surgery hospitals.

July 25, 2007 – Multidetector computed tomography (MDCT) angiography is highly accurate in depicting intracranial aneurysms, according to a study published in the August issue of Radiology. In addition, MDCT angiography can be used to quickly determine the possibility of using minimally invasive treatment rather than open surgery.

July 25, 2007 - Teleflex Incorporated, a diversified company expanding medical technology business, and Arrow International Inc., a provider of catheter-based access and therapeutic products for critical and cardiac care, announced that they have entered into a definitive agreement pursuant to which Teleflex will acquire Arrow in an all cash transaction valued at approximately $2 billion.

July 25, 2007 – Using 64-slice coronary CT angiography as a diagnostic test poses a substantial risk of developing radiation-induced cancer for women and younger patients, according to a study published in the Journal of the American Medical Association earlier this month.

July 25, 2007 - Researchers have confirmed that six new genetic variants increase the likelihood of developing coronary artery disease (CAD), according to a study by the University of Leicester and the University of Leeds, UK, and the Universities of Lubeck and Regensburg, Germnay, published by the journal New England Journal of Medicine.

July 25, 2007 – According to a study published in the July 25 issue of JAMA, high-risk patients with hypertrophic cardiomyopathy (HCM) may reduce the risk of sudden cardiac death with an implantable cardioverter-defibrillator that terminates dangerous heart rhythm disorders.

The studies indicates that clinicians have been using implantable cardioverter-defibrillator (ICD) as a potentially life-saving treatment in high-risk patients with HCM, however, the effectiveness and appropriate selection of HCM patients for this therapy remains uncertain.

July 25, 2007 - The Sudden Cardiac Arrest (SCA) Coalition announced the launch of a new website, www.stopcardiacarrest.org, designed to emphasize the Coalition’s efforts to stop cardiac arrest by providing information about the prevalence of SCA, possible risk factors, as well as provides tools and resources for how to learn even more, all demonstrating the need for greater research, awareness and access to treatment.

July 25, 2007 - St. Jude Medical, Inc. announced the first patient implant in its clinical trial of Trifecta, a new investigational stented, pericardial tissue heart valve, that will undergo a trial test its safety and efficacy as a replacement for the aortic valve.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now